Spire Capital Surpluse from 2010 to 2024

SPI Stock   225.50  6.00  2.73%   
Spire Healthcare's Capital Surpluse is decreasing over the years with slightly volatile fluctuation. Capital Surpluse is expected to dwindle to about 661.5 M. During the period from 2010 to 2024 Spire Healthcare Capital Surpluse annual values regression line had geometric mean of  808,987,526 and mean square error of 1562.9 T. View All Fundamentals
 
Capital Surpluse  
First Reported
2010-12-31
Previous Quarter
744.2 M
Current Value
661.5 M
Quarterly Volatility
46.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Spire Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Spire Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 77.8 M, Interest Expense of 72.1 M or Selling General Administrative of 88.2 M, as well as many indicators such as . Spire financial statements analysis is a perfect complement when working with Spire Healthcare Valuation or Volatility modules.
  
This module can also supplement various Spire Healthcare Technical models . Check out the analysis of Spire Healthcare Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Spire Stock

Spire Healthcare financial ratios help investors to determine whether Spire Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spire with respect to the benefits of owning Spire Healthcare security.